UPDATE : Friday, July 10, 2020
KoBioLabs' allergic immune disease treatment enters global clinical trial by Shim Hyun-tai 2020-03-23 16:03
Samsung Bioepis’ biosimilar breast cancer treatment scores FDA’s nod by Lee Han-soo 2020-03-20 16:52
Samsung Biologics makes CDO partnership with Taiwanese bio-venture by Lee Han-soo 2020-03-17 17:31
Celltrion Healthcare launches anticancer biosimilar Herzuma in US by Lee Han-soo 2020-03-17 16:21
‘Celltrion to invest ₩20 billion to develop COVID-19 cure in 6 months’ by Lee Han-soo 2020-03-13 17:38
SK Bioscience threatens MSD's sway over shingles vaccine market by Lee Han-soo 2020-03-12 17:05
Bridge Biotherapeutics, Atomwise to develop new drugs using AI by Lee Han-soo 2020-03-10 12:26
Celltrion applies for approval of new Humira biosimilar to EMA by Shim Hyun-tai 2020-03-09 16:40
Celltrion Healthcare’s 2019 sales top ₩1 trillion by Lee Han-soo 2020-03-06 17:31
Samsung BioLogics, STCube to develop immunotherapies by Lee Han-soo 2020-03-03 16:18
Celltrion Healthcare presents Remsima SC in UK by Lee Han-soo 2020-03-02 17:42
HLB seeks new pipelines by taking over US biotech firm by Jeong Sae-im 2020-02-21 15:42
Celltrion’s annual revenue surpassed ₩1 trillion in 2019 by Jeong Sae-im 2020-02-20 15:47
Prescription of Celltrion’s Remsima SC started in Germany by Jeong Sae-im 2020-02-18 16:05
Korea University analyzes 5,000 cancer patients’ genomic data  by Kim Yun-mi 2020-02-11 15:49
Sillajen's loss more than doubles due to Pexa-Vec trial failure by Jeong Sae-im 2020-02-03 16:08
Kolon CEO arrested for mislabeling Invossa’s ingredient by Jeong Sae-im 2020-02-03 15:34
Interpark embarks on organoid business by Park Gi-taek 2020-01-27 11:18
Samsung BioLogics’ annual sales up 30% on contract research growth by Jeong Sae-im 2020-01-23 14:47
Celltrion Group to build biopharmaceutical plant in China by Lee Han-soo 2020-01-21 18:00
Back to Top